ETF

LABU

Direxion Daily S&P Biotech Bull 3X Shares · NYSEArca

$276 +0.73% 1D Finazon · prior-day close · Aug 14, 2026

Price · Chart

Our own end-of-day closes 61 sessions

$350 $150 19 May 14 Aug

The line runs $157 on 19 May through $276 on 14 August, on a scale from $150 to $350. Days the market did not trade hold the previous close, flat.

The chart above plots the price of LABU over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $157 on 19 May 2026 through $276 on 14 August 2026.

52-week range $60 – $324

Avg volume 37.0K

Finazon · prior-day close · as of Aug 17, 2026

About the fund

The Fund seeks to provide daily investment results, before fees and expenses, equal to 300% of the daily performance of an index composed of U.S. biotechnology companies, as defined by the Global Industry Classification Standard (GICS) and selected from the S&P Total Market Index. It aims to achieve this leveraged exposure primarily through investments in financial instruments such as swaps and futures, as well as securities of the index or related ETFs. The Fund rebalances its portfolio daily to maintain its targeted leverage and may hold concentrated positions in the biotechnology industry to match the index's composition.

Fund facts

Exchange NYSEArca

Class ETF

LABU

Filings 1 set

LABU fails-to-deliver